Back to Search
Start Over
Global Prevalence of Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis.
- Source :
- Ocular Immunology & Inflammation; 2021, Vol. 29 Issue 1, p66-75, 10p
- Publication Year :
- 2021
-
Abstract
- Purpose: The purpose of this study is to assess the pooled prevalence of meibomian gland dysfunction (MGD) and evaluate its risk factors by gender, age, and ethnicity. Methods: Articles were searched reporting the prevalence of MGD from PubMed, Scopus, Web of Science, and Embase databases. Results: The estimated pooled prevalence of MGD was 0.358 (95% CI 0.26–0.46; I<superscript>2</superscript>: 99.57%). The prevalence of MGD was 0.358 (95% CI 0.24–0.50) in clinical and 0.359 (95% CI 0.22–0.52) in population-based studies. Men were more prone to MGD than women (OR: 1.24, 95% CI 1.01–1.52, p = 0.034). The rate of MGD was between 21.2% and 29.5% in Africans and Caucasians, to 71.0% in Arabs, and 67.5% in Hispanics. Conclusion: MGD is a quite prevalent disorder with an estimated pooled prevalence of 35.8%. Men are more prone to MGD than women. There is a large variation between studies in terms of quality, sample size, age ranges, diagnostic criteria, and ethnicity. [ABSTRACT FROM AUTHOR]
- Subjects :
- MEIBOMIAN glands
GENDER
SAMPLE size (Statistics)
ETHNICITY
Subjects
Details
- Language :
- English
- ISSN :
- 09273948
- Volume :
- 29
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Ocular Immunology & Inflammation
- Publication Type :
- Academic Journal
- Accession number :
- 148981557
- Full Text :
- https://doi.org/10.1080/09273948.2020.1755441